DRTS (Alpha Tau Medical Ltd.) רווח נקי למניה (EPS TTM)

Alpha Tau Medical Ltd. is implementing digital alpha-radiation dose calculation systems to minimize medical errors. The TTM EPS history clearly illustrates the profitability trend, while -1.04 captures the current state of the parameter. Alpha Tau Medical Ltd. is developing unique methods for the targeted destruction of solid tumors, maintaining stable equipment production on automated assembly lines with strict quality control.

Alpha Tau Medical Ltd. (DRTS) supplies specialized alpha-therapy systems to global oncology centers to combat resistant tumors. The effectiveness of this business model is quantified through equity income, where annual net profit is divided by the number of shares, allowing net earnings per share over the last four quarters to identify inflection points in profitability and recognize capital development trends in a timely manner.